2016

2016 (19 Publikationen)

  • Seuthe AM, Januschowski K, Szurman P. Micro-invasive 360-degree suture trabeculotomy after successful canaloplasty – one year results. Graefes Arch Clin Exp Ophthalmol. 2016; 254:155-159 [IF 1.991]
  • Spitzer MS, Nessmann A, Wagner J, Yoeruek E, Bartz-Schmidt KU, Szurman P, Szurman GB. Customized humanoptics silicone iris prosthesis in eyes with posttraumatic iris loss: outcomes and complications. Acta Ophthalmol. 2016; 94: 301-306 [IF 3.032]
  • Szurman P, Januschowski K, Boden KT, Szurman GB. A modified scleral dissection technique with suprachoroidal drainage for canaloplasty. Graefes Arch Clin Exp Ophthalmol. 2016; 254: 351-354 [IF 1.991]
  • Seuthe AM, Ivanescu C, Leers S, Boden K, Januschowski K, Szurman P. Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty-1-year results. Graefes Arch Clin Exp Ophthalmol. 2016; 254: 1591-1597 [IF 1.991]
  • Rickmann A, Szurman P, Januschowski K, Waizel M, Spitzer MS, Boden KT, Szurman GB. Long-term results after artificial iris implantation in patients with aniridia. Graefes Arch Clin Exp Ophthalmol 2016; 254: 1419-2524 [IF 1.991]
  • Waizel M, Rickmann A, Blanke BR, Wolf K, Kazerounian S, Szurman P. Response to bevacizumab after treatment with aflibercept in eyes with neovascular AMD. Eur J Ophthalmol 2016; 26: 469-472 [IF 1.068]
  • Januschowski K, Leers S, Haus A, Szurman P, Seuthe AM, Boden KT. Is trabeculectomy really superior to canaloplasty? Acta Ophthalmol 2016; 94:666-667 [IF 3.032]
  • Szurman GB, Januschowski K, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Dimopoulos S, Bevacizumab Study Group Venous Occlusion, Meyer CH. Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicentre study. Acta Ophthalmol 2016 Feb 1; [Epub ahead of print] [IF 3.032]
  • P. Szurman, K. Boden, K. Januschowski. Suprachoroidal hydrogel buckle as surgical treatment of retinal detachments – biocompatibility and first experiences. Retina 2016; 36: 1786-1790 [IF 3.243]
  • Szurman P, Januschowski K, Rickmann A, Damm LJ, Boden KT, Opitz N. Novel liquid bubble dissection technique for DMEK lenticule preparation. Graefes Arch Clin Exp Ophthalmol. 2016; 254: 1819-1823 [IF 1.991]
  • Süsskind D, Neuhann I, Hilgers RD, Hagemann U, Szurman P, Bartz-Schmidt KU, Aisenbrey S. Primary vitrectomy for rhegmatogenous retinal detachment in pseudophakic eyes: 20-gauge versus 25-gauge vitrectomy. Acta Ophthalmol. 2016; 94: 824-828 [IF 3.032]
  • Chryssafis C, Neubauer AS, Papadopoulos E, Januschowski K, Boden KT, Szurman P. Intensified intravitreal bevacizumab treatment regime for type 1 and 2 idiopathic macular telangiectasia. Inter J Ophthalmol 2016; 9: 1076-1078 [IF 0,939]
  • Januschowski K, Szurman P, Meyer CH, Feltgen N, Pielen A, Spitzer B, Rehak M, Spital G, Dimopoulos S, Dimopoulou A, Bevacizumab Study Group Venous Occlusion, Szurman GB. Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion. Graefes Arch Clin Exper Ophthalmol 2016; in press [IF 1.991]
  • Rickmann A, Waizel M, Kazerounian S, Szurman P, Boden KT. Relation of Pupil Size and Retinal Diseases. Int J Ophthalmol Eye Res 2016; 4; 242-245
  • Rickmann A, Waizel M, Szurman P, Boden KT. Relation of Pupil Size and Cataract Surgery using PupilX. Int J Ophthalmol Clin Res 2016; 3: 059
  • Mariacher S, Ebner M, Seuthe AM, Januschowski K, Ivanescu C, Opitz N, Szurman P, Boden KT. Femtosecond laser-assisted cataract surgery: First clinical results with special regard to central corneal thickness, endothelial cell count, and aqueous flare levels. J Cataract Refract Surg 2016; 42: 1151-1146.
  • Heider A, Dimopoulos S, Szurman P, Januschowski K. Real-life experience with intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes. Acta Ophthalmol 2016 Aug 8. [Epub ahead of print]
  • Mariacher S, Ebner M, Januschowski K, Hurst J, Schnichels S, Szurman P. Investigation of a novel implantable suprachoroidal pressure transducer for telemetric intraocular pressure monitoring. Exp Eye Res 2016; 151: 54-60.
  • Waizel M, Todorova MG, Kazerounian S, Rickmann A, Blanke BR, Szurman P. Efficacy of Vitrectomy Combined with Subretinal Recombinant Tissue Plasminogen Activator for Subretinal versus Subpigment Epithelial versus Combined Hemorrhages. Ophthalmologica 2016; 236: 123-132

Kontakt

Callcenter:
06897 / 574-1121

E-Mail-Formular

Notfallambulanz (Pforte, außerhalb der Callcenter-Sprechzeiten):
06897 / 574-0

Privatambulanz (Chefarzt-Sekretariat):
06897 / 574-1119

Adresse:
Augenklinik Sulzbach, An der Klinik 10
66280 Sulzbach

Anfahrt

Kontakt

Logo KHERI augenklinik saar

KTQ Zertifikat

Wussten Sie schon?

Unser hohes Maß an Qualität wurde uns als erster Klinik im Saarland offiziell zertifiziert. Das KTQ-Siegel steht für Patientenorientierung, geprüfte Qualität und Sicherheit.